Its worth noting that the added nutrients are at a pretty low level
According to Novo Nordisk, over 55 million Americans have commercial insurance coverage for Wegovy, with around 90% of those people paying $0 to $25 per month for the medication
If they are willing to self-fund, self-funding SGLT-2 inhibitor ($80-100/month) is cheaper than self-funding GLP-1 agonists ($150-250/month) DPP-4 inhibitor (e.g
These interventions include adopting healthy dietary patterns, such as the Mediterranean diet, minimizing processed foods and sugary drinks, engaging in regular physical activity, and avoiding smoking and excessive alcohol consumption
J Endocrinol (2014) 221(1):T3141
Quick Answer: GLP-1 receptor agonists do not directly cause frequent urination as a pharmacological effect, though some patients may experience urinary changes due to indirect factors like weight loss, improved glycemic control, or hydration changes